Results 111 to 120 of about 6,498,873 (334)
Conformation of Proteins and Polypeptides
Theodore T. Herskovits, Linda Mescanti
openalex +1 more source
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau+9 more
wiley +1 more source
Determination of protein conformation and orientation at buried solid/liquid interfaces. [PDF]
Guo W+5 more
europepmc +1 more source
On the Conformational Stability of Globular Proteins
Peter H. von Hippel, Kwok-Ying Wong
openalex +1 more source
Alteration of 5S RNA conformation by ribosomal proteins L18 and L25 [PDF]
David G. Bear+3 more
openalex +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp+13 more
wiley +1 more source
Effect of cavitation jet technology on instant solubility characteristics of soymilk flour: Based on the change of protein conformation in soymilk. [PDF]
Gong Q+8 more
europepmc +1 more source
Stereochemical Criteria for Polypeptide and Protein Chain Conformations
G. N. Ramachandran+2 more
openalex +1 more source
Conformational alteration of protein synthesis elongation factor EF-Tu by EF-Ts and by kirromycin. [PDF]
Thomas Blumenthal+2 more
openalex +1 more source
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source